FREE BIO-TECH STOCK CATALYST REPORT FOR WEEK OF 02-08-2026 TO 02-14-2026

Well well, The Seattle Seahawks take the Win in Super Bowl LX. This is what Google’s Gemini summarized regarding stock market prediction after the Win.

According to the superstitious “Super Bowl Indicator,” a Seattle Seahawks (NFC) win suggests a positive year for the stock market, as historically, NFC victories correlate with rising stocks for the remainder of that year. While this theory has been accurate in ~72% of cases, experts caution that it is a whimsical, non-fundamental correlation. 

  • The Theory: The Super Bowl Indicator posits that an NFC team winning (like the Seahawks) signals a bullish market, while an AFC team win signals a bearish year.
  • Historical Accuracy: While this theory has had a high success rate since 1978, it has actually been wrong more than half the time since 2000.
  • The 2026 Context: For Super Bowl 60, market analysts note that a Seahawks win is technically considered a “bullish” omen, but they advise investors to ignore this superstition, as it has no actual bearing on market performance. 

Historically, in 2015 when the Seahawks lost to the Patriots, it was a rare year where the market did not follow the expected trend, illustrating the randomness of the indicator.

And now, back to the BIO-TECH STOCK CATALYST REPORT.

We’re excited to announce the release of our latest free bio tech stock catalyst report for the upcoming week. This new free stock report highlights bio tech companies that have an upcoming important event to help traders and investors make informed decisions in today’s dynamic environment. Each stock symbol is a link to a stock quote page that further contains the news articles, outlining these company events.

Stay ahead with actionable intelligence designed for both seasoned professionals and individual investors seeking an edge in stock market analysis. Happy trading!

SYMBOLEVENTEVENT DATEPRICE POTENTIAL % (+/-)OPEN INTERESTPRICE $
$AZNClinical Trial02-13-20266.889,705193.03
$RGNXPDUFA02-08-202627.4185710.33
$GSKClinical Trial02-11-20264.395660.23
$IFRXClinical Trial02-13-202623.476130.89
$PFEClinical Trial02-13-20265.86349,91427.22
$TAKClinical Trial02-10-20266.325,46217.89
$AMGNClinical Trial02-13-20266.5431,413384.32
$NVSClinical Trial02-13-20265.375,005156.42
$KPTIClinical Trial02-08-202622.578,6666.26
WEEK: 02-08-2026 – 02-14-2026